Drug intelligence / Profile preview

desflurane + oxygen + nitric oxide

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation
01

Overview

This is a combination of three inhaled agents—desflurane, oxygen, and nitric oxide—used in anesthesia. Desflurane is a volatile halogenated ether anesthetic with rapid onset and offset due to its low blood-gas solubility. It acts primarily as a positive allosteric modulator at the GABA(A) receptor, also agonizing glycine receptors, antagonizing glutamate receptors (notably NMDA), inducing potassium channels, and inhibiting NADH-ubiquinone oxidoreductase chain 1 and calcium transporting ATPases[8]. Oxygen serves as an essential carrier gas for respiration during anesthesia. Nitric oxide (NO), when used in medical settings (distinct from nitrous oxide), acts as a selective pulmonary vasodilator by activating soluble guanylate cyclase in vascular smooth muscle cells, increasing cGMP levels and causing vasodilation; it is primarily used for pulmonary hypertension but may be included in specialized anesthetic regimens. The combination of these agents can provide general anesthesia with hemodynamic stability while allowing titration of oxygenation and pulmonary vascular resistance.

02

Targets

GABAA (Gamma-aminobutyric acid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)GLRA1 (Glycine receptor subunit Alpha-1)sGC (Soluble Guanylyl Cyclase)ATP2A (Sarcoplasmic reticulum Ca2+-ATPase)GRIA1 (AMPA receptor subunit GluA1)ND1 (Mitochondrial electron transport chain complex I)KCNA1 (Voltage-gated potassium channel subfamily A member 1)

Beyond the preview

Go deeper on desflurane + oxygen + nitric oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desflurane + oxygen + nitric oxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call